Illumina Body Map 2
Name | miRBASE accession |
---|---|
hsa-miR-27a-3p
|
MIMAT0000084 |
hsa-miR-27b-3p
|
MIMAT0000419 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_-_27183263 | 3.95 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
chr6_+_41606176 | 3.22 |
ENST00000441667.1
ENST00000230321.6 ENST00000373050.4 ENST00000446650.1 ENST00000435476.1 |
MDFI
|
MyoD family inhibitor |
chr1_+_40420802 | 2.86 |
ENST00000372811.5
ENST00000420632.2 ENST00000434861.1 ENST00000372809.5 |
MFSD2A
|
major facilitator superfamily domain containing 2A |
chr20_-_14318248 | 2.85 |
ENST00000378053.3
ENST00000341420.4 |
FLRT3
|
fibronectin leucine rich transmembrane protein 3 |
chr8_+_40010989 | 2.68 |
ENST00000315792.3
|
C8orf4
|
chromosome 8 open reading frame 4 |
chr1_-_47655686 | 2.66 |
ENST00000294338.2
|
PDZK1IP1
|
PDZK1 interacting protein 1 |
chr5_-_115910630 | 2.61 |
ENST00000343348.6
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chr17_-_46692287 | 2.50 |
ENST00000239144.4
|
HOXB8
|
homeobox B8 |
chr11_+_34642656 | 2.41 |
ENST00000257831.3
ENST00000450654.2 |
EHF
|
ets homologous factor |
chr6_-_39197226 | 2.40 |
ENST00000359534.3
|
KCNK5
|
potassium channel, subfamily K, member 5 |
chr8_+_120220561 | 2.27 |
ENST00000276681.6
|
MAL2
|
mal, T-cell differentiation protein 2 (gene/pseudogene) |
chr15_+_96873921 | 2.22 |
ENST00000394166.3
|
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr15_+_81071684 | 2.20 |
ENST00000220244.3
ENST00000394685.3 ENST00000356249.5 |
KIAA1199
|
KIAA1199 |
chr6_+_50786414 | 2.17 |
ENST00000344788.3
ENST00000393655.3 ENST00000263046.4 |
TFAP2B
|
transcription factor AP-2 beta (activating enhancer binding protein 2 beta) |
chr5_+_167718604 | 2.13 |
ENST00000265293.4
|
WWC1
|
WW and C2 domain containing 1 |
chr9_+_137533615 | 2.01 |
ENST00000371817.3
|
COL5A1
|
collagen, type V, alpha 1 |
chr8_+_76452097 | 1.98 |
ENST00000396423.2
|
HNF4G
|
hepatocyte nuclear factor 4, gamma |
chr15_-_79383102 | 1.94 |
ENST00000558480.2
ENST00000419573.3 |
RASGRF1
|
Ras protein-specific guanine nucleotide-releasing factor 1 |
chr8_+_134203273 | 1.84 |
ENST00000250160.6
|
WISP1
|
WNT1 inducible signaling pathway protein 1 |
chr7_-_81399438 | 1.84 |
ENST00000222390.5
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor) |
chr15_+_41221536 | 1.80 |
ENST00000249749.5
|
DLL4
|
delta-like 4 (Drosophila) |
chr1_-_95392635 | 1.77 |
ENST00000538964.1
ENST00000394202.4 ENST00000370206.4 |
CNN3
|
calponin 3, acidic |
chr19_-_36391434 | 1.73 |
ENST00000396901.1
ENST00000585925.1 |
NFKBID
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta |
chr4_+_55095264 | 1.73 |
ENST00000257290.5
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide |
chr4_+_85504075 | 1.72 |
ENST00000295887.5
|
CDS1
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 |
chr1_+_199996702 | 1.71 |
ENST00000367362.3
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2 |
chr9_+_103790991 | 1.70 |
ENST00000374874.3
|
LPPR1
|
Lipid phosphate phosphatase-related protein type 1 |
chr16_-_65155833 | 1.70 |
ENST00000566827.1
ENST00000394156.3 ENST00000562998.1 |
CDH11
|
cadherin 11, type 2, OB-cadherin (osteoblast) |
chr12_+_103981044 | 1.69 |
ENST00000388887.2
|
STAB2
|
stabilin 2 |
chr20_+_10199468 | 1.65 |
ENST00000254976.2
ENST00000304886.2 |
SNAP25
|
synaptosomal-associated protein, 25kDa |
chr9_-_136857403 | 1.60 |
ENST00000406606.3
ENST00000371850.3 |
VAV2
|
vav 2 guanine nucleotide exchange factor |
chr2_+_232260254 | 1.55 |
ENST00000287590.5
|
B3GNT7
|
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 |
chr10_-_15762124 | 1.53 |
ENST00000378076.3
|
ITGA8
|
integrin, alpha 8 |
chr12_-_88974236 | 1.50 |
ENST00000228280.5
ENST00000552044.1 ENST00000357116.4 |
KITLG
|
KIT ligand |
chr18_+_55102917 | 1.49 |
ENST00000491143.2
|
ONECUT2
|
one cut homeobox 2 |
chr2_+_43864387 | 1.46 |
ENST00000282406.4
|
PLEKHH2
|
pleckstrin homology domain containing, family H (with MyTH4 domain) member 2 |
chr11_+_58939965 | 1.44 |
ENST00000227451.3
|
DTX4
|
deltex homolog 4 (Drosophila) |
chr3_+_139654018 | 1.44 |
ENST00000458420.3
|
CLSTN2
|
calsyntenin 2 |
chr7_-_155604967 | 1.44 |
ENST00000297261.2
|
SHH
|
sonic hedgehog |
chr4_+_115519577 | 1.44 |
ENST00000310836.6
|
UGT8
|
UDP glycosyltransferase 8 |
chr6_-_119399895 | 1.44 |
ENST00000338891.7
|
FAM184A
|
family with sequence similarity 184, member A |
chr4_+_111397216 | 1.43 |
ENST00000265162.5
|
ENPEP
|
glutamyl aminopeptidase (aminopeptidase A) |
chr22_+_51112800 | 1.42 |
ENST00000414786.2
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3 |
chr4_+_20255123 | 1.42 |
ENST00000504154.1
ENST00000273739.5 |
SLIT2
|
slit homolog 2 (Drosophila) |
chr2_-_166651191 | 1.41 |
ENST00000392701.3
|
GALNT3
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3) |
chr7_-_103629963 | 1.41 |
ENST00000428762.1
ENST00000343529.5 ENST00000424685.2 |
RELN
|
reelin |
chr17_-_8534067 | 1.40 |
ENST00000360416.3
ENST00000269243.4 |
MYH10
|
myosin, heavy chain 10, non-muscle |
chr17_+_47572647 | 1.40 |
ENST00000172229.3
|
NGFR
|
nerve growth factor receptor |
chr1_-_200992827 | 1.40 |
ENST00000332129.2
ENST00000422435.2 |
KIF21B
|
kinesin family member 21B |
chr3_-_32022733 | 1.38 |
ENST00000438237.2
ENST00000396556.2 |
OSBPL10
|
oxysterol binding protein-like 10 |
chrX_-_54384425 | 1.38 |
ENST00000375169.3
ENST00000354646.2 |
WNK3
|
WNK lysine deficient protein kinase 3 |
chr11_-_88796803 | 1.37 |
ENST00000418177.2
ENST00000455756.2 |
GRM5
|
glutamate receptor, metabotropic 5 |
chr11_+_121322832 | 1.33 |
ENST00000260197.7
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
chr5_-_176981417 | 1.32 |
ENST00000514747.1
ENST00000443375.2 ENST00000329540.5 |
FAM193B
|
family with sequence similarity 193, member B |
chr22_-_37823468 | 1.32 |
ENST00000402918.2
|
ELFN2
|
extracellular leucine-rich repeat and fibronectin type III domain containing 2 |
chr9_+_116917807 | 1.32 |
ENST00000356083.3
|
COL27A1
|
collagen, type XXVII, alpha 1 |
chr5_-_121413974 | 1.31 |
ENST00000231004.4
|
LOX
|
lysyl oxidase |
chr21_+_35445827 | 1.31 |
ENST00000608209.1
ENST00000381151.3 |
SLC5A3
SLC5A3
|
sodium/myo-inositol cotransporter solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 |
chr11_+_130029457 | 1.29 |
ENST00000278742.5
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma) |
chr9_+_118916082 | 1.27 |
ENST00000328252.3
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1 |
chr3_+_36421826 | 1.25 |
ENST00000273183.3
|
STAC
|
SH3 and cysteine rich domain |
chr2_-_27718052 | 1.24 |
ENST00000264703.3
|
FNDC4
|
fibronectin type III domain containing 4 |
chr2_+_192542850 | 1.24 |
ENST00000410026.2
|
NABP1
|
nucleic acid binding protein 1 |
chr1_-_68299130 | 1.24 |
ENST00000370982.3
|
GNG12
|
guanine nucleotide binding protein (G protein), gamma 12 |
chr7_-_108096822 | 1.24 |
ENST00000379028.3
ENST00000413765.2 ENST00000379022.4 |
NRCAM
|
neuronal cell adhesion molecule |
chr8_-_60031762 | 1.23 |
ENST00000361421.1
|
TOX
|
thymocyte selection-associated high mobility group box |
chr20_-_41818373 | 1.23 |
ENST00000373187.1
ENST00000356100.2 ENST00000373184.1 ENST00000373190.1 |
PTPRT
|
protein tyrosine phosphatase, receptor type, T |
chr5_+_172068232 | 1.21 |
ENST00000520919.1
ENST00000522853.1 ENST00000369800.5 |
NEURL1B
|
neuralized E3 ubiquitin protein ligase 1B |
chr5_+_52285144 | 1.21 |
ENST00000296585.5
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
chr2_+_46524537 | 1.19 |
ENST00000263734.3
|
EPAS1
|
endothelial PAS domain protein 1 |
chr20_+_49348081 | 1.19 |
ENST00000371610.2
|
PARD6B
|
par-6 family cell polarity regulator beta |
chr5_-_57756087 | 1.18 |
ENST00000274289.3
|
PLK2
|
polo-like kinase 2 |
chr1_-_57045228 | 1.17 |
ENST00000371250.3
|
PPAP2B
|
phosphatidic acid phosphatase type 2B |
chr5_+_132149017 | 1.15 |
ENST00000378693.2
|
SOWAHA
|
sosondowah ankyrin repeat domain family member A |
chr6_+_19837592 | 1.14 |
ENST00000378700.3
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein |
chr21_+_33245548 | 1.13 |
ENST00000270112.2
|
HUNK
|
hormonally up-regulated Neu-associated kinase |
chr1_-_108507631 | 1.12 |
ENST00000527011.1
ENST00000370056.4 |
VAV3
|
vav 3 guanine nucleotide exchange factor |
chr15_+_80987617 | 1.12 |
ENST00000258884.4
ENST00000558464.1 |
ABHD17C
|
abhydrolase domain containing 17C |
chr12_+_54422142 | 1.10 |
ENST00000243108.4
|
HOXC6
|
homeobox C6 |
chr3_+_32859510 | 1.10 |
ENST00000383763.5
|
TRIM71
|
tripartite motif containing 71, E3 ubiquitin protein ligase |
chr6_+_127439749 | 1.09 |
ENST00000356698.4
|
RSPO3
|
R-spondin 3 |
chr15_-_37390482 | 1.08 |
ENST00000559085.1
ENST00000397624.3 |
MEIS2
|
Meis homeobox 2 |
chr9_-_130742792 | 1.08 |
ENST00000373095.1
|
FAM102A
|
family with sequence similarity 102, member A |
chr15_-_63674218 | 1.07 |
ENST00000178638.3
|
CA12
|
carbonic anhydrase XII |
chr18_+_19749386 | 1.06 |
ENST00000269216.3
|
GATA6
|
GATA binding protein 6 |
chr10_+_89419370 | 1.04 |
ENST00000361175.4
ENST00000456849.1 |
PAPSS2
|
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
chr9_-_38069208 | 1.02 |
ENST00000377707.3
ENST00000377700.4 |
SHB
|
Src homology 2 domain containing adaptor protein B |
chr1_+_160370344 | 1.02 |
ENST00000368061.2
|
VANGL2
|
VANGL planar cell polarity protein 2 |
chr2_-_165697920 | 1.02 |
ENST00000342193.4
ENST00000375458.2 |
COBLL1
|
cordon-bleu WH2 repeat protein-like 1 |
chr14_+_52118576 | 1.02 |
ENST00000395718.2
ENST00000344768.5 |
FRMD6
|
FERM domain containing 6 |
chr13_-_107187462 | 1.01 |
ENST00000245323.4
|
EFNB2
|
ephrin-B2 |
chr6_+_136172820 | 1.00 |
ENST00000308191.6
|
PDE7B
|
phosphodiesterase 7B |
chrX_+_17393543 | 1.00 |
ENST00000380060.3
|
NHS
|
Nance-Horan syndrome (congenital cataracts and dental anomalies) |
chr6_+_391739 | 1.00 |
ENST00000380956.4
|
IRF4
|
interferon regulatory factor 4 |
chr11_+_14665263 | 1.00 |
ENST00000282096.4
|
PDE3B
|
phosphodiesterase 3B, cGMP-inhibited |
chr8_-_122653630 | 0.99 |
ENST00000303924.4
|
HAS2
|
hyaluronan synthase 2 |
chr6_+_126112001 | 0.99 |
ENST00000392477.2
|
NCOA7
|
nuclear receptor coactivator 7 |
chr8_+_80523321 | 0.97 |
ENST00000518111.1
|
STMN2
|
stathmin-like 2 |
chr10_-_21786179 | 0.97 |
ENST00000377113.5
|
CASC10
|
cancer susceptibility candidate 10 |
chr1_+_955448 | 0.96 |
ENST00000379370.2
|
AGRN
|
agrin |
chr11_-_86666427 | 0.96 |
ENST00000531380.1
|
FZD4
|
frizzled family receptor 4 |
chr1_-_48462566 | 0.96 |
ENST00000606738.2
|
TRABD2B
|
TraB domain containing 2B |
chr2_-_235405679 | 0.96 |
ENST00000390645.2
|
ARL4C
|
ADP-ribosylation factor-like 4C |
chr8_-_127570603 | 0.95 |
ENST00000304916.3
|
FAM84B
|
family with sequence similarity 84, member B |
chr17_-_36831156 | 0.95 |
ENST00000325814.5
|
C17orf96
|
chromosome 17 open reading frame 96 |
chr11_-_102826434 | 0.95 |
ENST00000340273.4
ENST00000260302.3 |
MMP13
|
matrix metallopeptidase 13 (collagenase 3) |
chr3_+_122785895 | 0.95 |
ENST00000316218.7
|
PDIA5
|
protein disulfide isomerase family A, member 5 |
chr4_+_56815102 | 0.94 |
ENST00000257287.4
|
CEP135
|
centrosomal protein 135kDa |
chr17_+_59529743 | 0.94 |
ENST00000589003.1
ENST00000393853.4 |
TBX4
|
T-box 4 |
chr6_+_114178512 | 0.92 |
ENST00000368635.4
|
MARCKS
|
myristoylated alanine-rich protein kinase C substrate |
chr1_-_204329013 | 0.91 |
ENST00000272203.3
ENST00000414478.1 |
PLEKHA6
|
pleckstrin homology domain containing, family A member 6 |
chr19_-_43969796 | 0.90 |
ENST00000244333.3
|
LYPD3
|
LY6/PLAUR domain containing 3 |
chr3_-_116164306 | 0.90 |
ENST00000490035.2
|
LSAMP
|
limbic system-associated membrane protein |
chr5_-_179780312 | 0.89 |
ENST00000253778.8
|
GFPT2
|
glutamine-fructose-6-phosphate transaminase 2 |
chr14_-_39901618 | 0.89 |
ENST00000554932.1
ENST00000298097.7 |
FBXO33
|
F-box protein 33 |
chr19_+_45251804 | 0.88 |
ENST00000164227.5
|
BCL3
|
B-cell CLL/lymphoma 3 |
chr15_+_81293254 | 0.88 |
ENST00000267984.2
|
MESDC1
|
mesoderm development candidate 1 |
chr10_+_112257596 | 0.88 |
ENST00000369583.3
|
DUSP5
|
dual specificity phosphatase 5 |
chr7_+_94285637 | 0.87 |
ENST00000482108.1
ENST00000488574.1 |
PEG10
|
paternally expressed 10 |
chr11_+_369804 | 0.86 |
ENST00000329962.6
|
B4GALNT4
|
beta-1,4-N-acetyl-galactosaminyl transferase 4 |
chr6_-_99873145 | 0.84 |
ENST00000369239.5
ENST00000438806.1 |
PNISR
|
PNN-interacting serine/arginine-rich protein |
chr1_-_48227290 | 0.84 |
ENST00000594280.1
|
FLJ00388
|
FLJ00388 |
chr15_+_33010175 | 0.84 |
ENST00000300177.4
ENST00000560677.1 ENST00000560830.1 |
GREM1
|
gremlin 1, DAN family BMP antagonist |
chr19_+_51815102 | 0.84 |
ENST00000270642.8
|
IGLON5
|
IgLON family member 5 |
chr2_-_20212422 | 0.84 |
ENST00000421259.2
ENST00000407540.3 |
MATN3
|
matrilin 3 |
chr12_+_79258547 | 0.83 |
ENST00000457153.2
|
SYT1
|
synaptotagmin I |
chr5_+_110559784 | 0.83 |
ENST00000282356.4
|
CAMK4
|
calcium/calmodulin-dependent protein kinase IV |
chr16_-_68482440 | 0.83 |
ENST00000219334.5
|
SMPD3
|
sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) |
chr6_+_30524663 | 0.83 |
ENST00000376560.3
|
PRR3
|
proline rich 3 |
chr19_+_15218180 | 0.82 |
ENST00000342784.2
ENST00000597977.1 ENST00000600440.1 |
SYDE1
|
synapse defective 1, Rho GTPase, homolog 1 (C. elegans) |
chrX_-_74145273 | 0.82 |
ENST00000055682.6
|
KIAA2022
|
KIAA2022 |
chr10_-_90712520 | 0.81 |
ENST00000224784.6
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
chr1_+_65613217 | 0.80 |
ENST00000545314.1
|
AK4
|
adenylate kinase 4 |
chr11_+_101981169 | 0.78 |
ENST00000526343.1
ENST00000282441.5 ENST00000537274.1 ENST00000345877.2 |
YAP1
|
Yes-associated protein 1 |
chr10_+_60272814 | 0.78 |
ENST00000373886.3
|
BICC1
|
bicaudal C homolog 1 (Drosophila) |
chr12_-_54673871 | 0.77 |
ENST00000209875.4
|
CBX5
|
chromobox homolog 5 |
chr20_-_62610982 | 0.77 |
ENST00000369886.3
ENST00000450107.1 |
SAMD10
|
sterile alpha motif domain containing 10 |
chr3_-_164913777 | 0.77 |
ENST00000475390.1
|
SLITRK3
|
SLIT and NTRK-like family, member 3 |
chr3_-_134093395 | 0.76 |
ENST00000249883.5
|
AMOTL2
|
angiomotin like 2 |
chr12_-_49351303 | 0.76 |
ENST00000256682.4
|
ARF3
|
ADP-ribosylation factor 3 |
chr12_-_77272765 | 0.76 |
ENST00000547435.1
ENST00000552330.1 ENST00000546966.1 ENST00000311083.5 |
CSRP2
|
cysteine and glycine-rich protein 2 |
chrX_+_78426469 | 0.76 |
ENST00000276077.1
|
GPR174
|
G protein-coupled receptor 174 |
chr3_+_152879985 | 0.75 |
ENST00000323534.2
|
RAP2B
|
RAP2B, member of RAS oncogene family |
chr8_-_41166953 | 0.75 |
ENST00000220772.3
|
SFRP1
|
secreted frizzled-related protein 1 |
chr5_-_160279207 | 0.75 |
ENST00000327245.5
|
ATP10B
|
ATPase, class V, type 10B |
chr1_+_117452669 | 0.75 |
ENST00000393203.2
|
PTGFRN
|
prostaglandin F2 receptor inhibitor |
chr1_-_206945830 | 0.75 |
ENST00000423557.1
|
IL10
|
interleukin 10 |
chr15_+_29131103 | 0.75 |
ENST00000558402.1
ENST00000558330.1 |
APBA2
|
amyloid beta (A4) precursor protein-binding, family A, member 2 |
chr12_+_50135588 | 0.75 |
ENST00000423828.1
ENST00000550445.1 |
TMBIM6
|
transmembrane BAX inhibitor motif containing 6 |
chr16_+_1756162 | 0.74 |
ENST00000250894.4
ENST00000356010.5 |
MAPK8IP3
|
mitogen-activated protein kinase 8 interacting protein 3 |
chr9_+_114659046 | 0.74 |
ENST00000374279.3
|
UGCG
|
UDP-glucose ceramide glucosyltransferase |
chr16_+_577697 | 0.74 |
ENST00000562370.1
ENST00000568988.1 ENST00000219611.2 |
CAPN15
|
calpain 15 |
chr2_+_204801471 | 0.74 |
ENST00000316386.6
ENST00000435193.1 |
ICOS
|
inducible T-cell co-stimulator |
chr9_+_130830451 | 0.74 |
ENST00000373068.2
ENST00000373069.5 |
SLC25A25
|
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 25 |
chr19_+_45973120 | 0.73 |
ENST00000592811.1
ENST00000586615.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
chr5_-_38595498 | 0.73 |
ENST00000263409.4
|
LIFR
|
leukemia inhibitory factor receptor alpha |
chr6_+_168841817 | 0.73 |
ENST00000356284.2
ENST00000354536.5 |
SMOC2
|
SPARC related modular calcium binding 2 |
chr7_+_20370746 | 0.73 |
ENST00000222573.4
|
ITGB8
|
integrin, beta 8 |
chr10_+_8096631 | 0.73 |
ENST00000379328.3
|
GATA3
|
GATA binding protein 3 |
chr5_-_59995921 | 0.73 |
ENST00000453022.2
ENST00000545085.1 ENST00000265036.5 |
DEPDC1B
|
DEP domain containing 1B |
chr1_+_228194693 | 0.73 |
ENST00000284523.1
ENST00000366753.2 |
WNT3A
|
wingless-type MMTV integration site family, member 3A |
chr7_+_100210133 | 0.72 |
ENST00000393950.2
ENST00000424091.2 |
MOSPD3
|
motile sperm domain containing 3 |
chr3_+_11034403 | 0.72 |
ENST00000287766.4
ENST00000425938.1 |
SLC6A1
|
solute carrier family 6 (neurotransmitter transporter), member 1 |
chr15_+_59730348 | 0.72 |
ENST00000288228.5
ENST00000559628.1 ENST00000557914.1 ENST00000560474.1 |
FAM81A
|
family with sequence similarity 81, member A |
chr11_+_120081475 | 0.71 |
ENST00000328965.4
|
OAF
|
OAF homolog (Drosophila) |
chr13_+_24734844 | 0.71 |
ENST00000382108.3
|
SPATA13
|
spermatogenesis associated 13 |
chr1_+_176432298 | 0.71 |
ENST00000367661.3
ENST00000367662.3 |
PAPPA2
|
pappalysin 2 |
chr12_-_106641728 | 0.70 |
ENST00000378026.4
|
CKAP4
|
cytoskeleton-associated protein 4 |
chr13_+_33160553 | 0.70 |
ENST00000315596.10
|
PDS5B
|
PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) |
chr9_+_132934835 | 0.70 |
ENST00000372398.3
|
NCS1
|
neuronal calcium sensor 1 |
chr4_-_147442982 | 0.70 |
ENST00000511374.1
ENST00000264986.3 |
SLC10A7
|
solute carrier family 10, member 7 |
chr17_+_1958388 | 0.70 |
ENST00000399849.3
|
HIC1
|
hypermethylated in cancer 1 |
chr11_-_67888671 | 0.69 |
ENST00000265689.4
|
CHKA
|
choline kinase alpha |
chr17_+_8924837 | 0.69 |
ENST00000173229.2
|
NTN1
|
netrin 1 |
chr17_+_72983674 | 0.69 |
ENST00000337231.5
|
CDR2L
|
cerebellar degeneration-related protein 2-like |
chr5_-_43313574 | 0.68 |
ENST00000325110.6
ENST00000433297.2 |
HMGCS1
|
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) |
chr7_-_75368248 | 0.68 |
ENST00000434438.2
ENST00000336926.6 |
HIP1
|
huntingtin interacting protein 1 |
chr5_-_1524015 | 0.67 |
ENST00000283415.3
|
LPCAT1
|
lysophosphatidylcholine acyltransferase 1 |
chr17_+_38375574 | 0.67 |
ENST00000323571.4
ENST00000585043.1 ENST00000394103.3 ENST00000536600.1 |
WIPF2
|
WAS/WASL interacting protein family, member 2 |
chr21_-_39870339 | 0.67 |
ENST00000429727.2
ENST00000398905.1 ENST00000398907.1 ENST00000453032.2 ENST00000288319.7 |
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog |
chr12_-_92539614 | 0.66 |
ENST00000256015.3
|
BTG1
|
B-cell translocation gene 1, anti-proliferative |
chr5_+_74632993 | 0.66 |
ENST00000287936.4
|
HMGCR
|
3-hydroxy-3-methylglutaryl-CoA reductase |
chr20_+_34700333 | 0.66 |
ENST00000441639.1
|
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chr16_+_23847339 | 0.65 |
ENST00000303531.7
|
PRKCB
|
protein kinase C, beta |
chr19_+_1286097 | 0.65 |
ENST00000215368.2
|
EFNA2
|
ephrin-A2 |
chr21_-_44846999 | 0.65 |
ENST00000270162.6
|
SIK1
|
salt-inducible kinase 1 |
chr1_+_82266053 | 0.65 |
ENST00000370715.1
ENST00000370713.1 ENST00000319517.6 ENST00000370717.2 ENST00000394879.1 ENST00000271029.4 ENST00000335786.5 |
LPHN2
|
latrophilin 2 |
chr8_-_22550815 | 0.65 |
ENST00000317216.2
|
EGR3
|
early growth response 3 |
chr15_+_84322827 | 0.64 |
ENST00000286744.5
ENST00000567476.1 |
ADAMTSL3
|
ADAMTS-like 3 |
chrX_+_105066524 | 0.63 |
ENST00000243300.9
ENST00000428173.2 |
NRK
|
Nik related kinase |
chr6_+_142622991 | 0.63 |
ENST00000230173.6
ENST00000367608.2 |
GPR126
|
G protein-coupled receptor 126 |
chr22_-_44258360 | 0.63 |
ENST00000330884.4
ENST00000249130.5 |
SULT4A1
|
sulfotransferase family 4A, member 1 |
chr17_+_15848231 | 0.62 |
ENST00000304222.2
|
ADORA2B
|
adenosine A2b receptor |
chr2_-_9143786 | 0.62 |
ENST00000462696.1
ENST00000305997.3 |
MBOAT2
|
membrane bound O-acyltransferase domain containing 2 |
chr1_+_220701456 | 0.62 |
ENST00000366918.4
ENST00000402574.1 |
MARK1
|
MAP/microtubule affinity-regulating kinase 1 |
chr20_+_3776371 | 0.61 |
ENST00000245960.5
|
CDC25B
|
cell division cycle 25B |
chr12_-_120907459 | 0.61 |
ENST00000229390.3
|
SRSF9
|
serine/arginine-rich splicing factor 9 |
chr17_-_80056099 | 0.61 |
ENST00000306749.2
|
FASN
|
fatty acid synthase |
chr7_-_92463210 | 0.60 |
ENST00000265734.4
|
CDK6
|
cyclin-dependent kinase 6 |
chr10_+_104474207 | 0.60 |
ENST00000602831.1
ENST00000369893.5 |
SFXN2
|
sideroflexin 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 3.9 | GO:0060435 | bronchiole development(GO:0060435) |
0.7 | 2.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.6 | 1.9 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.6 | 2.8 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.6 | 2.2 | GO:0009956 | radial pattern formation(GO:0009956) |
0.5 | 3.2 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.5 | 1.5 | GO:0033024 | mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.5 | 1.4 | GO:0060738 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) positive regulation of immature T cell proliferation in thymus(GO:0033092) right lung development(GO:0060458) primary prostatic bud elongation(GO:0060516) epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
0.5 | 1.4 | GO:0071623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.4 | 1.3 | GO:1902771 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
0.4 | 1.7 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.4 | 2.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.4 | 1.2 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.4 | 0.8 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.4 | 0.7 | GO:0100012 | regulation of heart induction(GO:0090381) regulation of heart induction by canonical Wnt signaling pathway(GO:0100012) |
0.4 | 1.1 | GO:0007493 | endodermal cell fate determination(GO:0007493) |
0.3 | 1.4 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.3 | 1.0 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.3 | 2.3 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.3 | 1.0 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.3 | 0.6 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
0.3 | 1.7 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.3 | 0.3 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.3 | 1.1 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.3 | 0.8 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.3 | 0.8 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.3 | 2.7 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.3 | 1.0 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 0.8 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.2 | 0.7 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.2 | 1.0 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 1.7 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.2 | 1.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.2 | 1.0 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.2 | 1.0 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.2 | 0.7 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.2 | 2.2 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.2 | 0.9 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 4.2 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.2 | 0.6 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.2 | 1.2 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 2.4 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.2 | 1.7 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 1.9 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.2 | 1.3 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.2 | 1.3 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 1.3 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.2 | 1.4 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
0.2 | 0.7 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.2 | 1.4 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.2 | 0.7 | GO:0061289 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.2 | 0.3 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.2 | 1.0 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.2 | 1.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.7 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.2 | 0.6 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 2.3 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.2 | 0.8 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.2 | 1.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.5 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.2 | 0.6 | GO:0060720 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.2 | 1.8 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.2 | 2.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.4 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.1 | 0.7 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.6 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.1 | 0.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.8 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.1 | 0.4 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 2.9 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.1 | 1.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.5 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.1 | 1.1 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.2 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
0.1 | 0.5 | GO:0071314 | cellular response to cocaine(GO:0071314) |
0.1 | 0.3 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 1.0 | GO:0003383 | apical constriction(GO:0003383) |
0.1 | 0.1 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.1 | 1.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.1 | 0.2 | GO:0060913 | cardiac cell fate determination(GO:0060913) |
0.1 | 0.7 | GO:1904721 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.1 | 0.3 | GO:0072573 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) |
0.1 | 2.4 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.4 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.5 | GO:0036371 | protein localization to T-tubule(GO:0036371) |
0.1 | 0.2 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.1 | 0.3 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.1 | 0.5 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.1 | 0.4 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.1 | 2.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.7 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.1 | 0.4 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.1 | 2.2 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 1.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 1.1 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.1 | 0.4 | GO:1902683 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) regulation of receptor localization to synapse(GO:1902683) |
0.1 | 1.7 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.1 | 0.4 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 0.9 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.3 | GO:1904237 | regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904235) positive regulation of substrate-dependent cell migration, cell attachment to substrate(GO:1904237) |
0.1 | 0.2 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.1 | 0.8 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.1 | 0.5 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.1 | 0.4 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.1 | 0.2 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.1 | 2.1 | GO:0021516 | dorsal spinal cord development(GO:0021516) |
0.1 | 0.9 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.4 | GO:0060611 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.1 | 0.5 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.1 | 0.5 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 0.4 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.1 | 1.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 1.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.1 | 0.7 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.1 | 0.3 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 0.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.5 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 0.6 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.1 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.3 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.1 | 1.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.8 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.1 | 0.2 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.9 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 1.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.6 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.1 | 0.5 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.6 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 1.9 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
0.1 | 0.7 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.7 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.1 | 0.2 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
0.1 | 0.6 | GO:0097491 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.1 | 1.1 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 1.7 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.6 | GO:0043697 | dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
0.1 | 0.5 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
0.0 | 0.6 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.0 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.0 | 0.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.0 | 0.7 | GO:0015866 | ADP transport(GO:0015866) |
0.0 | 0.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.0 | 0.6 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 1.0 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.0 | 0.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.0 | 0.7 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.2 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) |
0.0 | 0.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.3 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.4 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.2 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.0 | 0.5 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.2 | GO:1904075 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.0 | 1.0 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 1.4 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.0 | 0.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.0 | 0.3 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.0 | 1.1 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.0 | 0.3 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.0 | 0.4 | GO:0018211 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.3 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.6 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 1.0 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.4 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.0 | 0.6 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.1 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.0 | 0.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.0 | 1.5 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 | 0.2 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.0 | 0.2 | GO:1904382 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.0 | 0.2 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.0 | 0.1 | GO:0021586 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.0 | 0.2 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.0 | 1.5 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.0 | 0.4 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 1.2 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.1 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.0 | 1.2 | GO:0060674 | placenta blood vessel development(GO:0060674) |
0.0 | 0.3 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.0 | 0.3 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.0 | 0.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.2 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.1 | GO:0007619 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
0.0 | 0.8 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.5 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.0 | 1.7 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.0 | 0.4 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.8 | GO:0034389 | lipid particle organization(GO:0034389) |
0.0 | 0.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
0.0 | 0.4 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.4 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.0 | 0.2 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.0 | 0.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.0 | 1.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 1.1 | GO:0032456 | endocytic recycling(GO:0032456) |
0.0 | 0.0 | GO:1905007 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) |
0.0 | 0.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.1 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.5 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.0 | 0.5 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.3 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.0 | 0.2 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.0 | 0.7 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.0 | 0.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 0.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 0.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.2 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.6 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.2 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.0 | 0.2 | GO:0060395 | SMAD protein signal transduction(GO:0060395) |
0.0 | 0.2 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.0 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.6 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 1.0 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.7 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.0 | GO:2001038 | regulation of cellular response to drug(GO:2001038) |
0.0 | 0.3 | GO:0051412 | response to corticosterone(GO:0051412) |
0.0 | 0.1 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.1 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 0.1 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
0.0 | 0.4 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.0 | 0.5 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.2 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.0 | 0.0 | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
0.0 | 0.1 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.0 | GO:2000794 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) epithelial cell proliferation involved in lung morphogenesis(GO:0060502) innate vocalization behavior(GO:0098582) regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
0.0 | 0.4 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.1 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
0.0 | 0.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 1.2 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 1.1 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
0.0 | 0.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 1.4 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.0 | 0.1 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.0 | 0.1 | GO:1990403 | embryonic brain development(GO:1990403) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 1.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.3 | 1.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.3 | 1.0 | GO:0060187 | cell pole(GO:0060187) |
0.3 | 1.5 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.2 | 0.7 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.2 | 1.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.2 | 0.9 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.9 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.2 | 1.7 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.2 | 0.8 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 0.5 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.2 | 0.5 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
0.2 | 0.8 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.2 | 1.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 0.5 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
0.1 | 0.4 | GO:1990032 | parallel fiber(GO:1990032) |
0.1 | 0.8 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.1 | 1.4 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 0.3 | GO:0009346 | citrate lyase complex(GO:0009346) |
0.1 | 0.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.1 | 0.1 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.1 | 0.8 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 1.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 0.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 2.8 | GO:0044295 | axonal growth cone(GO:0044295) |
0.1 | 1.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.5 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.4 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 0.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.1 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.0 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.5 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.4 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.0 | 0.2 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.0 | 0.2 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.0 | 0.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.0 | 0.2 | GO:0001740 | Barr body(GO:0001740) |
0.0 | 1.0 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.7 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.2 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.0 | 0.2 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.0 | 0.6 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 0.7 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.0 | 0.4 | GO:0044327 | dendritic spine head(GO:0044327) |
0.0 | 0.7 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 1.2 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.7 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.0 | 0.1 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.4 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 1.4 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 1.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.0 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 1.9 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 2.4 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 3.5 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 4.4 | GO:0043296 | apical junction complex(GO:0043296) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 2.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 8.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 0.4 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 0.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 1.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 2.1 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.0 | 0.6 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.3 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.6 | GO:0044433 | cytoplasmic vesicle part(GO:0044433) |
0.0 | 1.4 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 1.1 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.7 | GO:0030120 | vesicle coat(GO:0030120) |
0.0 | 0.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.5 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 1.4 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.3 | GO:0005365 | myo-inositol transmembrane transporter activity(GO:0005365) |
0.4 | 1.7 | GO:0005018 | platelet-derived growth factor alpha-receptor activity(GO:0005018) |
0.4 | 1.7 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.4 | 1.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 1.4 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.3 | 1.0 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.3 | 2.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.3 | 1.5 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.2 | 0.7 | GO:0004103 | choline kinase activity(GO:0004103) |
0.2 | 0.7 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.2 | 0.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 0.6 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.2 | 0.6 | GO:0031177 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) S-acetyltransferase activity(GO:0016418) phosphopantetheine binding(GO:0031177) |
0.2 | 0.6 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.2 | 1.0 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.6 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
0.2 | 0.7 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.2 | 0.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.7 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.2 | 1.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 1.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.1 | 0.6 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.1 | 1.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.7 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.1 | 1.4 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.1 | 1.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 3.4 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.8 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.1 | 4.2 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.1 | 2.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 2.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.3 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 1.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.3 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
0.1 | 3.5 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 1.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 2.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 2.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.7 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 0.5 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.1 | 0.7 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.1 | 1.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.5 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.1 | 0.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.1 | 0.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 0.8 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.1 | 1.0 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.1 | 1.2 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.1 | 1.0 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 2.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.1 | 0.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 1.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.4 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.1 | 0.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 1.2 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.2 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
0.1 | 0.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 1.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 0.2 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.1 | 0.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 0.6 | GO:0047144 | 2-acylglycerol-3-phosphate O-acyltransferase activity(GO:0047144) |
0.1 | 0.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.6 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.0 | 0.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 3.8 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.7 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 2.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 1.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.0 | 0.6 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.0 | 0.9 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.4 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.0 | 1.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.4 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 1.8 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.4 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.0 | 0.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 1.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.0 | 0.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.0 | 0.6 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 1.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 0.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 0.9 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.5 | GO:0015297 | antiporter activity(GO:0015297) |
0.0 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.3 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.1 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.0 | 1.0 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 1.2 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 1.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 2.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 1.7 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.5 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 1.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 1.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.7 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.7 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.8 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 1.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 12.4 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 1.4 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.3 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0004651 | polynucleotide 5'-phosphatase activity(GO:0004651) |
0.0 | 0.1 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.0 | 0.0 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.0 | 0.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.0 | 1.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.5 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.0 | 0.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.0 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.4 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.2 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.2 | GO:0015924 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.0 | 0.3 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 1.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.0 | 0.1 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.0 | 0.3 | GO:0031996 | thioesterase binding(GO:0031996) |
0.0 | 2.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.0 | 0.7 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.0 | 0.4 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
0.0 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.0 | 1.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 0.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.0 | 0.4 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.0 | 1.3 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 1.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.4 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.0 | 1.0 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 1.2 | GO:0005518 | collagen binding(GO:0005518) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 0.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 3.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 3.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 1.4 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 3.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 2.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.3 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 4.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 2.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 2.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 1.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.7 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 1.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 1.7 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.0 | 0.2 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 1.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.8 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 1.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 1.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 1.2 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 6.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.7 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.8 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 1.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.1 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 4.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.6 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 0.2 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 1.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.7 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.8 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 0.6 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.1 | 1.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 2.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.1 | 1.4 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.1 | 2.7 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.1 | 3.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 2.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 2.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 3.3 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 0.1 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.1 | 1.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 3.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.0 | 0.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 3.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.5 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.0 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 1.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.0 | 1.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 1.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.9 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.0 | 1.5 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 1.3 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 1.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.9 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 1.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 3.1 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 1.2 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 2.3 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.8 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 1.4 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 1.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.9 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.0 | 0.4 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.0 | 0.1 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 1.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.4 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 2.7 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 1.5 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.0 | 1.8 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.0 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 1.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 0.8 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 1.0 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.6 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 0.5 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |